Sufentanil sublingual tablet system in the treatment of acute postoperative pain in adults: a profile of its use

Sufentanil sublingual tablet system in the treatment of acute postoperative pain in adults: a... The novel sufentanil sublingual tablet system (sufentanil STS; Zalviso®) provides an alternative option to opioid-based intravenous patient-controlled analgesia (IV PCA) for the management of acute moderate to severe postoperative pain in adults in the hospital setting. It overcomes some of the drawbacks associated with opioid-based IV PCA, as the preprogrammed, noninvasive design of the sufentanil STS avoids the risk of pump programming errors and other complications that can occur with IV PCA technology. With each device activation, the patient-controlled sufentanil STS device delivers a sublingual sufentanil 15 μg nanotablet, with patients self-administering to analgesia by varying the interval between doses (minimum between-dose interval 20 min; maximum recommended treatment duration 72 h). Relative to morphine IV PCA, sufentanil delivered by the STS is as effective in relieving post-operative pain with a more rapid onset of analgesia and, according to patient and healthcare professional assessments, provides higher rates of success and overall satisfaction, and is easier to use. Sublingual sufentanil is generally well tolerated, with an adverse event profile typical of that of other opioids and a relatively low risk of respiratory depression. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drugs & Therapy Perspectives Springer Journals

Sufentanil sublingual tablet system in the treatment of acute postoperative pain in adults: a profile of its use

Loading next page...
 
/lp/springer_journal/sufentanil-sublingual-tablet-system-in-the-treatment-of-acute-BTLn7vr6WQ
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Pharmacy; Pharmacy; Pharmacotherapy
ISSN
1172-0360
eISSN
1179-1977
D.O.I.
10.1007/s40267-017-0434-6
Publisher site
See Article on Publisher Site

Abstract

The novel sufentanil sublingual tablet system (sufentanil STS; Zalviso®) provides an alternative option to opioid-based intravenous patient-controlled analgesia (IV PCA) for the management of acute moderate to severe postoperative pain in adults in the hospital setting. It overcomes some of the drawbacks associated with opioid-based IV PCA, as the preprogrammed, noninvasive design of the sufentanil STS avoids the risk of pump programming errors and other complications that can occur with IV PCA technology. With each device activation, the patient-controlled sufentanil STS device delivers a sublingual sufentanil 15 μg nanotablet, with patients self-administering to analgesia by varying the interval between doses (minimum between-dose interval 20 min; maximum recommended treatment duration 72 h). Relative to morphine IV PCA, sufentanil delivered by the STS is as effective in relieving post-operative pain with a more rapid onset of analgesia and, according to patient and healthcare professional assessments, provides higher rates of success and overall satisfaction, and is easier to use. Sublingual sufentanil is generally well tolerated, with an adverse event profile typical of that of other opioids and a relatively low risk of respiratory depression.

Journal

Drugs & Therapy PerspectivesSpringer Journals

Published: Jul 31, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off